PlainRecalls
FDA Drug Moderate Class II Terminated

Ranitidine 300 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-455-30

Reported: October 14, 2020 Initiated: January 15, 2020 #D-0017-2021

Product Description

Ranitidine 300 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-455-30

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Details

Recalling Firm
Direct Rx
Units Affected
26 bottles
Distribution
FL, GA
Location
Dawsonville, GA

Frequently Asked Questions

What product was recalled?
Ranitidine 300 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-455-30. Recalled by Direct Rx. Units affected: 26 bottles.
Why was this product recalled?
CGMP Deviations: Presence of NDMA impurity detected in product.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 14, 2020. Severity: Moderate. Recall number: D-0017-2021.